207 related articles for article (PubMed ID: 6146820)
1. Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group.
Sawada T; Hirayama M; Nakata T; Takeda T; Takasugi N; Mori T; Maeda K; Koide R; Hanawa Y; Tsunoda A
Lancet; 1984 Aug; 2(8397):271-3. PubMed ID: 6146820
[TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma. Mass screening for early detection and its prognosis.
Sawada T; Kidowaki T; Sakamoto I; Hashida T; Matsumura T; Nakagawa M; Kusunoki T
Cancer; 1984 Jun; 53(12):2731-5. PubMed ID: 6722733
[TBL] [Abstract][Full Text] [Related]
3. Stephen L. Gans overseas lecture. Mass screening for neuroblastoma in Japan: lessons learned and future directions.
Suita S
J Pediatr Surg; 2002 Jul; 37(7):949-54. PubMed ID: 12077747
[TBL] [Abstract][Full Text] [Related]
4. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
[TBL] [Abstract][Full Text] [Related]
5. Imaging evaluation of infants with neuroblastoma detected by VMA screening spot test.
Fujioka M; Saiki N; Aihara T; Yamamoto K
Pediatr Radiol; 1988; 18(6):479-83. PubMed ID: 3054769
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma of the urinary bladder, preclinically detected by mass screening.
Yokoyama S; Hirakawa H; Ueno S; Yabe H; Hiraoka N
Pediatrics; 1999 May; 103(5):e67. PubMed ID: 10224211
[TBL] [Abstract][Full Text] [Related]
7. Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 month olds.
Hayashi Y; Ohi R; Yaoita S; Nakamura M; Kikuchi Y; Konno T; Tsuchiya S; Shiraishi H
J Pediatr Surg; 1995 Mar; 30(3):467-70. PubMed ID: 7760244
[TBL] [Abstract][Full Text] [Related]
8. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
[TBL] [Abstract][Full Text] [Related]
9. VMA mass screening program of neuroblastoma for infants in Nagoya City, Japan.
Kodama K; Nakata T; Ishii J; Mitani K; Tsunooka H; Masaoka A; Aoyama M
Am J Public Health; 1985 Feb; 75(2):173-5. PubMed ID: 3966625
[TBL] [Abstract][Full Text] [Related]
10. Incidence of neuroblastoma in infancy in Japan.
Sawada T; Kidowaki T; Sugimoto T; Kusunoki T
Med Pediatr Oncol; 1984; 12(2):101-3. PubMed ID: 6700544
[TBL] [Abstract][Full Text] [Related]
11. Mass screening of neuroblastoma in infancy.
Sawada T; Todo S; Fujita K; Iino S; Imashuku S; Kusunoki T
Am J Dis Child; 1982 Aug; 136(8):710-2. PubMed ID: 6808827
[TBL] [Abstract][Full Text] [Related]
12. Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
Takeda T; Shimada M; Iizuka S; Takasugi N
Prog Clin Biol Res; 1994; 385():383-8. PubMed ID: 7972235
[TBL] [Abstract][Full Text] [Related]
13. Screening for neuroblastoma: a review of the evidence.
Chamberlain J
J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
[TBL] [Abstract][Full Text] [Related]
14. A trial to discriminate spontaneous regression from non-regression cases during mass screening for neuroblastoma.
Nishi M; Miyake H; Takeda T; Yonemori H; Hanai J; Kikuchi Y; Takasugi N
Jpn J Clin Oncol; 1994 Oct; 24(5):247-51. PubMed ID: 7967103
[TBL] [Abstract][Full Text] [Related]
15. Imaging of neuroblastoma in patients identified by mass screening using urinary catecholamine metabolites.
Tanabe M; Yoshida H; Ohnuma N; Iwai J; Takahashi H
J Pediatr Surg; 1993 Apr; 28(4):617-21. PubMed ID: 8483079
[TBL] [Abstract][Full Text] [Related]
16. Number and cure rate of neuroblastoma cases detected by the mass screening program in Japan: future aspects.
Sawada T; Sugimoto T; Tanaka T; Kawakatsu H; Ishii T; Matsumura T; Horii Y
Med Pediatr Oncol; 1987; 15(1):14-7. PubMed ID: 3561327
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of mass screening for neuroblastoma in infancy.
Sawada T; Matsumura T; Kawakatsu H; Sugimoto T; Kuroda H; Hosoi H; Michihata T; Saida T; Hino T
Am J Pediatr Hematol Oncol; 1991; 13(1):3-7. PubMed ID: 2029075
[TBL] [Abstract][Full Text] [Related]
18. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
[TBL] [Abstract][Full Text] [Related]
19. Bilateral adrenal neuroblastoma.
Ishiguro Y; Iio K; Seo T; Nagaya M; Ito T
Eur J Pediatr Surg; 1994 Feb; 4(1):37-9. PubMed ID: 8199131
[TBL] [Abstract][Full Text] [Related]
20. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]